» Articles » PMID: 33674612

Dynamic Control of the Dopamine Transporter in Neurotransmission and Homeostasis

Overview
Date 2021 Mar 6
PMID 33674612
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

The dopamine transporter (DAT) transports extracellular dopamine into the intracellular space contributing to the regulation of dopamine neurotransmission. A reduction of DAT density is implicated in Parkinson's disease (PD) by neuroimaging; dopamine turnover is dopamine turnover is elevated in early symptomatic PD and in presymptomatic individuals with monogenic mutations causal for parkinsonism. As an integral plasma membrane protein, DAT surface expression is dynamically regulated through endocytic trafficking, enabling flexible control of dopamine signaling in time and space, which in turn critically modulates movement, motivation and learning behavior. Yet the cellular machinery and functional implications of DAT trafficking remain enigmatic. In this review we summarize mechanisms governing DAT trafficking under normal physiological conditions and discuss how PD-linked mutations may disturb DAT homeostasis. We highlight the complexity of DAT trafficking and reveal DAT dysregulation as a common theme in genetic models of parkinsonism.

Citing Articles

Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer's and Parkinson's Diseases.

Puranik N, Song M Neurol Int. 2025; 17(2).

PMID: 39997657 PMC: 11858632. DOI: 10.3390/neurolint17020026.


The kinase LRRK2 is required for the physiological function and expression of the glial glutamate transporter EAAT2 (SLC1A2).

Di Iacovo A, DAgostino C, Bhatt M, Romanazzi T, Giovannardi S, Cinquetti R J Neurochem. 2024; 169(1):e16265.

PMID: 39655696 PMC: 11629453. DOI: 10.1111/jnc.16265.


Monoamine transporter ubiquitination and inward-open conformation synergistically maximize transporter endocytosis.

Sorkina T, Bagalkot T, Cheng M, Guthrie D, Newman A, Watkins S Sci Adv. 2024; 10(47):eadq9793.

PMID: 39576869 PMC: 11584022. DOI: 10.1126/sciadv.adq9793.


Dopamine in Sports: A Narrative Review on the Genetic and Epigenetic Factors Shaping Personality and Athletic Performance.

Huminska-Lisowska K Int J Mol Sci. 2024; 25(21).

PMID: 39519153 PMC: 11546834. DOI: 10.3390/ijms252111602.


Chronic Cocaine Use and Parkinson's Disease: An Interpretative Model.

Carbone M, Maremmani I Int J Environ Res Public Health. 2024; 21(8).

PMID: 39200714 PMC: 11354226. DOI: 10.3390/ijerph21081105.


References
1.
Wile D, Agarwal P, Schulzer M, Mak E, Dinelle K, Shahinfard E . Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies. Lancet Neurol. 2017; 16(5):351-359. PMC: 5477770. DOI: 10.1016/S1474-4422(17)30056-X. View

2.
Sossi V, de la Fuente-Fernandez R, Nandhagopal R, Schulzer M, McKenzie J, Ruth T . Dopamine turnover increases in asymptomatic LRRK2 mutations carriers. Mov Disord. 2010; 25(16):2717-23. DOI: 10.1002/mds.23356. View

3.
Lee C, Samii A, Sossi V, Ruth T, Schulzer M, Holden J . In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann Neurol. 2000; 47(4):493-503. View

4.
Sossi V, de la Fuente-Fernandez R, Holden J, Doudet D, McKenzie J, Stoessl A . Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data. J Cereb Blood Flow Metab. 2002; 22(2):232-9. DOI: 10.1097/00004647-200202000-00011. View

5.
Matsuda W, Furuta T, Nakamura K, Hioki H, Fujiyama F, Arai R . Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci. 2009; 29(2):444-53. PMC: 6664950. DOI: 10.1523/JNEUROSCI.4029-08.2009. View